OVERSEA CHINESE BANKING Corp Ltd Takes $669,000 Position in CME Group Inc. $CME

OVERSEA CHINESE BANKING Corp Ltd purchased a new stake in shares of CME Group Inc. (NASDAQ:CME) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 2,451 shares of the financial services provider’s stock, valued at approximately $669,000.

Several other institutional investors and hedge funds have also modified their holdings of the stock. West Family Investments Inc. grew its holdings in shares of CME Group by 1.2% during the 3rd quarter. West Family Investments Inc. now owns 3,062 shares of the financial services provider’s stock valued at $827,000 after acquiring an additional 37 shares in the last quarter. Asset Dedication LLC grew its holdings in shares of CME Group by 64.9% during the 4th quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 37 shares in the last quarter. Rehmann Capital Advisory Group grew its holdings in shares of CME Group by 4.3% during the 3rd quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider’s stock valued at $243,000 after acquiring an additional 37 shares in the last quarter. Atlatl Advisers LLC grew its holdings in shares of CME Group by 1.8% during the 3rd quarter. Atlatl Advisers LLC now owns 2,126 shares of the financial services provider’s stock valued at $574,000 after acquiring an additional 38 shares in the last quarter. Finally, 1248 Management LLC grew its holdings in shares of CME Group by 26.8% during the 3rd quarter. 1248 Management LLC now owns 180 shares of the financial services provider’s stock valued at $49,000 after acquiring an additional 38 shares in the last quarter. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on CME shares. JPMorgan Chase & Co. boosted their price target on shares of CME Group from $266.00 to $271.00 and gave the company an “underweight” rating in a report on Thursday, April 16th. UBS Group restated a “neutral” rating and set a $310.00 price target on shares of CME Group in a report on Friday, February 6th. Barclays lowered their price target on shares of CME Group from $344.00 to $343.00 and set an “equal weight” rating on the stock in a report on Monday, April 13th. Raymond James Financial boosted their price target on shares of CME Group from $310.00 to $320.00 and gave the company an “outperform” rating in a report on Monday, April 6th. Finally, Morgan Stanley upped their price objective on shares of CME Group from $340.00 to $362.00 and gave the stock an “overweight” rating in a report on Friday, April 10th. Two equities research analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating, six have issued a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, CME Group has an average rating of “Moderate Buy” and an average target price of $309.94.

CME Group Trading Up 0.5%

Shares of NASDAQ:CME opened at $285.71 on Thursday. The stock has a market capitalization of $102.46 billion, a PE ratio of 25.60, a P/E/G ratio of 2.90 and a beta of 0.26. CME Group Inc. has a 1 year low of $251.90 and a 1 year high of $329.16. The firm has a fifty day moving average price of $305.19 and a 200 day moving average price of $285.92. The company has a current ratio of 1.03, a quick ratio of 1.03 and a debt-to-equity ratio of 0.12.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.11 by $0.25. The firm had revenue of $1.88 billion during the quarter, compared to analysts’ expectations of $1.77 billion. CME Group had a net margin of 62.45% and a return on equity of 14.65%. CME Group’s revenue for the quarter was up 14.5% on a year-over-year basis. During the same period in the prior year, the company posted $2.80 earnings per share. Analysts expect that CME Group Inc. will post 12.37 EPS for the current fiscal year.

CME Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, March 26th. Investors of record on Tuesday, March 10th were issued a $1.30 dividend. This is a boost from CME Group’s previous quarterly dividend of $1.25. This represents a $5.20 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date was Tuesday, March 10th. CME Group’s dividend payout ratio is currently 46.59%.

Insider Buying and Selling at CME Group

In related news, General Counsel Jonathan L. Marcus sold 3,291 shares of the company’s stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $333.37, for a total value of $1,097,120.67. Following the completion of the sale, the general counsel directly owned 7,192 shares in the company, valued at approximately $2,397,597.04. This represents a 31.39% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Dennis Suskind sold 748 shares of the business’s stock in a transaction on Friday, February 6th. The stock was sold at an average price of $300.00, for a total transaction of $224,400.00. Following the transaction, the director directly owned 2,699 shares of the company’s stock, valued at approximately $809,700. This represents a 21.70% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 8,539 shares of company stock valued at $2,713,821. Company insiders own 0.30% of the company’s stock.

Key Stories Impacting CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Record top-line and volume: CME reported record Q1 revenue (~$1.9B) and adjusted operating income, with average daily volume up roughly 22% year-over-year — supportive for fee and clearing revenue. CME Group Inc. Reports Record Revenue, Adjusted Operating Income, Adjusted Net Income and Adjusted Earnings Per Share for Q1 2026
• Positive Sentiment: Earnings call tone: Management framed results as a broad-based, record surge in activity across products — which supports ongoing revenue durability if elevated market risk and volumes persist. CME Group Earnings Call Shows Broad-Based Record Surge
• Neutral Sentiment: Mixed vs. estimates: EPS came in at $3.36 — ahead of some street consensus but a penny or two shy of other analyst models; revenue grew ~14% y/y but comparisons to varying estimates produced differing headlines. That nuance explains split headlines. CME Group (CME) Q1 Earnings and Revenues Miss Estimates
• Neutral Sentiment: Analyst and institutional positioning: Wall Street targets remain above current levels on average (median targets ~$324), while some large funds trimmed positions — a factor that can add volatility but not necessarily change the fundamental outlook. CME GROUP ($CME) Releases Q1 2026 Earnings
• Negative Sentiment: Near-term market reaction / profit-taking: Some outlets flagged a “double miss” narrative and intraday weakness after the print — investors punished the stock where expectations were highest despite strong volume metrics. Watch for post-earnings volatility. CME Stock Under Pressure After Double Miss
• Negative Sentiment: Durability question: Several analysts and write-ups caution that record Q1 volumes set a high bar — the key risk is whether elevated market risk and volumes are sustainable into later quarters. CME Group earnings ahead: Record volumes face sustainability test

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.